MARKET

NTRBW

NTRBW

Nutriband
NASDAQ
1.120
-0.405
-26.56%
Closed 15:30 05/13 EDT
OPEN
1.140
PREV CLOSE
1.525
HIGH
1.140
LOW
1.120
VOLUME
2.14K
TURNOVER
0
52 WEEK HIGH
4.500
52 WEEK LOW
0.8000
MARKET CAP
--
P/E (TTM)
-0.4340
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at NTRB last week (0504-0508)?
Weekly Report · 3d ago
Weekly Report: what happened at NTRB last week (0427-0501)?
Weekly Report · 05/04 10:37
Nutriband FY26 net loss narrows to $8.23 million; revenue slips to $2.04 million
PUBT · 04/29 21:39
Weekly Report: what happened at NTRB last week (0420-0424)?
Weekly Report · 04/27 10:41
Nutriband CEO Sheridan discusses fentanyl crisis, AVERSA technology on Jack Neel Podcast
PUBT · 04/22 11:05
Weekly Report: what happened at NTRB last week (0413-0417)?
Weekly Report · 04/20 10:36
Weekly Report: what happened at NTRB last week (0406-0410)?
Weekly Report · 04/13 10:41
Nutriband Advances Lead Abuse-Deterrent Fentanyl Patch Branding
TipRanks · 04/07 19:58
More
About NTRBW
Nutriband Inc. is engaged in the development of a portfolio of transdermal pharmaceutical products. Its development pipeline consists of transdermal products that are based on proprietary AVERSA abuse-deterrent transdermal technology. Its lead product under development is AVERSA Fentanyl, an abuse deterrent fentanyl transdermal system that combines an approved generic fentanyl patch with its AVERSA abuse deterrent transdermal technology to reduce the abuse and misuse of fentanyl patches. Its development pipeline also includes AVERSA Buprenorphine and AVERSA Methylphenidate. It is developing a portfolio of transdermal pharmaceutical products to deliver already approved drugs or biologics that are typically delivered by injection but with the potential to improve compliance and therapeutic outcomes through transdermal delivery. AVERSA technology can be incorporated into any transdermal patch to prevent the abuse, misuse, diversion, and accidental exposure of drugs with abuse potential.

Webull offers Nutriband Inc stock information, including NASDAQ: NTRBW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NTRBW stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NTRBW stock methods without spending real money on the virtual paper trading platform.